Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1985 Feb;118(2):316–324.

Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.

L M Weiss, G S Crabtree, R V Rouse, R A Warnke
PMCID: PMC1887884  PMID: 3155915

Abstract

Fifty T-cell lymphomas, excluding mycosis fungoides and lymphoblastic lymphoma, were studied morphologically and immunohistochemically with a panel of monoclonal antibodies reactive with T-cell differentiation antigens in fresh frozen tissue. Histologically, 36% of the lymphomas were large-cell immunoblastic, 26% were diffuse large-cell, 22% were diffuse mixed small and large-cell, and 16% were monomorphic medium-sized-cell lymphomas. By immunologic studies, 64% of the lymphomas were of helper phenotype, 12% were of cytotoxic/suppressor phenotype, 8% expressed both helper and cytotoxic/suppressor suppressor antigenic markers, and 16% lacked detectable markers for either helper or cytotoxic/suppressor cells. There was no correlation between histologic category and immunophenotype. A common finding, and one which may prove to be helpful in the diagnosis of T-cell lymphomas, was the loss of one or more of the pan-T antigens Leu 1, 4, and 5 or the T-cell antigen Leu 9 in 32 cases. The expression of Leu 1 and Leu 9 was lost in 46% of cases, expression of Leu 4 was lost in 26%, and expression of Leu 5 was lost in 24%. About three-quarters of the lymphomas expressed Ia antigens.

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard A., Boumsell L., Reinherz E. L., Nadler L. M., Ritz J., Coppin H., Richard Y., Valensi F., Dausset J., Flandrin G. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood. 1981 Jun;57(6):1105–1110. [PubMed] [Google Scholar]
  2. Brisbane J. U., Berman L. D., Neiman R. S. Peripheral T-cell lymphoma: a clinicopathologic study of nine cases. Am J Clin Pathol. 1983 Mar;79(3):285–293. doi: 10.1093/ajcp/79.3.285. [DOI] [PubMed] [Google Scholar]
  3. Cossman J., Chused T. M., Fisher R. I., Magrath I., Bollum F., Jaffe E. S. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res. 1983 Sep;43(9):4486–4490. [PubMed] [Google Scholar]
  4. Doggett R. S., Wood G. S., Horning S., Levy R., Dorfman R. F., Bindl J., Warnke R. A. The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol. 1984 May;115(2):245–252. [PMC free article] [PubMed] [Google Scholar]
  5. Edelson R. L. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol. 1980 Feb;2(2):89–106. doi: 10.1016/s0190-9622(80)80385-9. [DOI] [PubMed] [Google Scholar]
  6. Jaffe E. S., Blattner W. A., Blayney D. W., Bunn P. A., Jr, Cossman J., Robert-Guroff M., Gallo R. C. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. Am J Surg Pathol. 1984 Apr;8(4):263–275. doi: 10.1097/00000478-198404000-00003. [DOI] [PubMed] [Google Scholar]
  7. Kadin M. E., Berard C. W., Nanba K., Wakasa H. Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States--Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol. 1983 Sep;14(9):745–772. doi: 10.1016/s0046-8177(83)80299-8. [DOI] [PubMed] [Google Scholar]
  8. Knowles D. M., 2nd, Halper J. P. Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases. Am J Pathol. 1982 Feb;106(2):187–203. [PMC free article] [PubMed] [Google Scholar]
  9. Link M., Warnke R., Finlay J., Amylon M., Miller R., Dilley J., Levy R. A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Blood. 1983 Oct;62(4):722–728. [PubMed] [Google Scholar]
  10. Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  11. Lukes R. J., Parker J. W., Taylor C. R., Tindle B. H., Cramer A. D., Lincoln T. L. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin Hematol. 1978 Oct;15(4):322–351. [PubMed] [Google Scholar]
  12. Lutzner M., Edelson R., Schein P., Green I., Kirkpatrick C., Ahmed A. Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med. 1975 Oct;83(4):534–552. doi: 10.7326/0003-4819-83-4-534. [DOI] [PubMed] [Google Scholar]
  13. Nathwani B. N., Kim H., Rappaport H. Malignant lymphoma, lymphoblastic. Cancer. 1976 Aug;38(2):964–983. doi: 10.1002/1097-0142(197608)38:2<964::aid-cncr2820380248>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  14. Palutke M., Tabaczka P., Weise R. W., Axelrod A., Palacas C., Margolis H., Khilanani P., Ratanatharathorn V., Piligian J., Pollard R. T-cell lymphomas of large cell type. A variety of malignant lymphomas: "histiocytic" and mixed lymphocytic-"histiocytic". Cancer. 1980 Jul 1;46(1):87–101. doi: 10.1002/1097-0142(19800701)46:1<87::aid-cncr2820460117>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  15. Pinkus G. S., Said J. W., Hargreaves H. Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobated nuclei, with a report of four cases. Am J Clin Pathol. 1979 Oct;72(4):540–550. doi: 10.1093/ajcp/72.4.540. [DOI] [PubMed] [Google Scholar]
  16. Reinherz E. L., Schlossman S. F. The differentiation and function of human T lymphocytes. Cell. 1980 Apr;19(4):821–827. doi: 10.1016/0092-8674(80)90072-0. [DOI] [PubMed] [Google Scholar]
  17. Suchi T., Tajima K., Nanba K., Wakasa H., Mikata A., Kikuchi M., Mori S., Watanabe S., Mohri N., Shamoto M. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type. Acta Pathol Jpn. 1979 Sep;29(5):755–776. doi: 10.1111/j.1440-1827.1979.tb00942.x. [DOI] [PubMed] [Google Scholar]
  18. Waldron J. A., Leech J. H., Glick A. D., Flexner J. M., Collins R. D. Malignant lymphoma of peripheral T-lymphocyte origin: immunologic, pathologic, and clinical features in six patients. Cancer. 1977 Oct;40(4):1604–1617. doi: 10.1002/1097-0142(197710)40:4<1604::aid-cncr2820400433>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  19. Warnke R., Miller R., Grogan T., Pederson M., Dilley J., Levy R. Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. N Engl J Med. 1980 Aug 7;303(6):293–300. doi: 10.1056/NEJM198008073030601. [DOI] [PubMed] [Google Scholar]
  20. Watanabe S., Shimosato Y., Shimoyama M., Minato K., Suzuki M., Abe M., Nagatani T. Adult T cell lymphoma with hypergammaglobulinemia. Cancer. 1980 Dec 1;46(11):2472–2483. doi: 10.1002/1097-0142(19801201)46:11<2472::aid-cncr2820461128>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  21. Weisenburger D. D., Nathwani B. N., Forman S. J., Rappaport H. Noncutaneous peripheral T-cell lymphoma histologically resembling mycosis fungoides. Cancer. 1982 May 1;49(9):1839–1847. doi: 10.1002/1097-0142(19820501)49:9<1839::aid-cncr2820490917>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  22. Wood G. S., Burke J. S., Horning S., Doggett R. S., Levy R., Warnke R. A. The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. Blood. 1983 Aug;62(2):464–472. [PubMed] [Google Scholar]
  23. Wood G. S., Warnke R. A. The immunologic phenotyping of bone marrow biopsies and aspirates: frozen section techniques. Blood. 1982 May;59(5):913–922. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES